Search
Search Results
-
Selenopeptide nanomedicine ameliorates atherosclerosis by reducing monocyte adhesions and inflammations
Atherosclerosis is an inflammatory disease that may cause severe heart disease and stroke. Current pharmacotherapy for atherosclerosis shows limited...
-
Resolvin D1 delivery to lesional macrophages using antioxidative black phosphorus nanosheets for atherosclerosis treatment
The buildup of plaques in atherosclerosis leads to cardiovascular events, with chronic unresolved inflammation and overproduction of reactive oxygen...
-
Thylakoid engineered M2 macrophage for sonodynamic effect promoted cell therapy of early atherosclerosis
Atherosclerosis is the most common cause of cardiovascular diseases that contribute to the major morbidity worldwide, but still lacking of effective...
-
Thoracic interstitial injection of drug-liposomes in mice for treating atherosclerosis
Intervaginal space injection (ISI) is a novel mode of administration investigated over the last decade. After injecting nanoparticles into the...
-
Regulation of the macrophage-related inflammatory micro-environment for atherosclerosis treatment and angiogenesis via anti-cytokine agents
Macrophages-mediated atherosclerosis (AS) is an inflammatory disease and the most common cause of ischemia. With the progress of basic and clinical...
-
RETRACTED ARTICLE: Down-regulation of microRNA-342-5p or Up-regulation of Wnt3a Inhibits Angiogenesis and Maintains Atherosclerotic Plaque Stability in Atherosclerosis Mice
Evidence has demonstrated that microRNA-342-5p (miR-342-5p) is implicated in atherosclerosis (AS), but little is known regarding its intrinsic...
-
High density lipoprotein mimicking nanoparticles for atherosclerosis
Atherosclerosis is a major contributor to many cardiovascular events, including myocardial infarction, ischemic stroke, and peripheral arterial...
-
Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis
Atherosclerosis is the process that underlies heart attack and stroke. A characteristic feature of the atherosclerotic plaque is the accumulation of...
-
Oral nanoparticles containing naringenin suppress atherosclerotic progression by targeting delivery to plaque macrophages
Atherosclerosis is the main cause of ischemic stroke and myocardial infarction diseases. Nanoparticles have shown unique benefits for atherosclerosis...
-
Macrophage-targeted and clearable glutathione-based MRI nanoprobes for atherosclerosis molecular imaging
Foam macrophage infiltration is one of the clinical features of high-risk atherosclerotic plaques. Many imaging modalities such as magnetic resonance...
-
Macrophage membrane-coated biomimetic magnetic nanoparticle loaded with interleukin 10 as potential candidate towards anti-atherosclerotic therapy: characterization and in vitro studies
Atherosclerosis is the main cause of most cardiovascular events. At present, the drugs that have been approved for the treatment of atherosclerosis...
-
The “two-pronged” nanosystem to precisely improve lipid metabolism and inflammatory microenvironment for atherosclerotic plaque stabilization
The rupture of atherosclerosis (AS) vulnerable plaque is the major cause of fatal arterial thrombosis related diseases. The lipid dysbolism and...
-
Liquid Metal Disease Therapy
Liquid metal (LM) is an emerging class of multifunctional material with unique advantages such as low toxicity, high mobility, and good electrical...
-
Investigating layer-by-layer chitosan-dextran sulfate-coated mesoporous silica as a pH-sensitive drug delivery system
Mesoporous silica nanoparticles (MSNPs) coated by chitosan (CS) were shown to be a proper candidate as a carrier for drug delivery purposes. However,...
-
Comparison of Numerical Model with Experimental Measurements for the Purpose of Testing Partially and Fully Biodegradable Stents
Atherosclerosis is a progressive disease characterized by the accumulation of lipids and fibrous elements in the arterial wall. This accumulation...
-
Curcumin attenuates inflammation of Macrophage-derived foam cells treated with Poly-L-lactic acid degradation via PPARγ signaling pathway
Poly-L-lactic acid (PLLA) is considered to be a promising candidate material for biodegradable vascular scaffolds (BVS) in percutaneous coronary...
-
Fluid–structure interaction analysis of non-Newtonian Herschel–Bulkley fluid viscosity model for pulsating flow of blood in ω-shaped stenosed arteries
AbstractThe present study investigated the transient pulsatile blood flow of Herschel–Bulkley fluid through tapered arteries with overlap**...
-
Nanomaterials for chronic inflammatory diseases: the current status and future prospects
Over the past decades, nanomedicine, the medical application of nanotechnology, has been extensively investigated as a promising approach in treating...
-
Simulants for Arteries
Arterial tissue refers to the tissues that make up arteries, which are blood vessels responsible for carrying oxygenated blood away from the heart to...